Covered recipient · General Payments record
SHERRY L MARTIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2024
$2,108.00
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $371.02 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $203.21 | 9 |
| ITI, Inc. | $57.30 | 2 |
| Vanda Pharmaceuticals Inc. | $43.35 | 2 |
| Alkermes, Inc. | $28.88 | 1 |
| Neurocrine BioSciences, Inc. | $20.50 | 1 |
| Indivior Inc. | $17.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.31 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107598013 | CMS |
| ABBVIE INC. | $34.63 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107598015 | CMS |
| ABBVIE INC. | $31.60 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107598017 | CMS |
| ABBVIE INC. | $15.57 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107598019 | CMS |
| ABBVIE INC. | $21.68 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107598021 | CMS |
| ABBVIE INC. | $21.38 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107598023 | CMS |
| ABBVIE INC. | $14.54 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107598025 | CMS |
| ABBVIE INC. | $18.82 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107598027 | CMS |
| ABBVIE INC. | $11.68 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107598029 | CMS |
| Alkermes, Inc. | $28.88 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120548480 | CMS |
| Indivior Inc. | $17.78 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144561869 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $25.13 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143541446 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $32.17 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143541448 | CMS |
| Neurocrine Biosciences, Inc. | $20.50 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150977206 | CMS |
| Vanda Pharmaceuticals Inc. | $28.63 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133956298 | CMS |
| Vanda Pharmaceuticals Inc. | $14.72 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133956300 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.